Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

NCT01009177

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations: Barwon Health - The Geelong Hospital Geelong, Australia

Sydney Haematology and Oncology Unit Hornsby, Australia

Cabrini Hopsital - Oncology Department Malvern, Australia

New Castle Melanoma Unit Newcastle, Australia

View Trial Details

Completed

A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

NCT03771859

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution - 0001 Brussels, Brussels Capital, Belgium

Local Institution Aalst, Belgium

Local Institution Antwerp, Belgium

Local Institution Bouge, Belgium

View all 14 locations

View Trial Details

Completed

Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.

NCT05542342

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Hospital Universitario Virgen de la Macarena Seville, Andalusia, Spain

Institut Catala Oncologia (ICO) L´Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Universitario la Paz Madrid, Spain

Hospital General Universitario de Valencia Valencia, Spain

View Trial Details

Completed

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

NCT02073123

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations: Augusta University Augusta, Georgia, United States

University of Iowa Hospital and Clinics Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

New Mexico Cancer Center Alliance Albuquerque, New Mexico, United States

View Trial Details

Completed

Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma

NCT02645149

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Westmead Hospital Westmead, New South Wales, Australia

Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Completed

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

NCT04305054

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +11 more
Locations: The Angeles Clinic and Research Institute ( Site 2009) Los Angeles, California, United States

UCLA Hematology & Oncology ( Site 2004) Los Angeles, California, United States

Providence Saint John's Health Center ( Site 2010) Santa Monica, California, United States

University of Colorado, Anschutz Cancer Pavilion ( Site 2012) Aurora, Colorado, United States

View all 60 locations

View Trial Details

Completed

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

NCT00600496

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +40 more
Locations: Research Site Detroit, Michigan, United States

Research Site Philadelphia, Pennsylvania, United States

Research Site Nashville, Tennessee, United States

Research Site Houston, Texas, United States

View Trial Details

Completed

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

NCT03336606

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cell Cancer, Squamous, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

NCT04253080

Conditions: Cutaneous Melanoma, Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, +11 more
Locations: Dermatology department Paris, Île-de-France Region, France

View Trial Details

Completed

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

NCT03304639

Conditions: Adenocarcinoma, Advanced Merkel Cell Carcinoma, Carcinoma, +21 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

View all 254 locations

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions